Sentencing is scheduled to begin in the criminal trial of top executives at Insys Therapeutics. This landmark case was the first successful prosecution of high-ranking pharmaceutical executives linked to the opioid crisis, including onetime billionaire John Kapoor.
After a 10-week trial and 15 days of jury deliberations, Kapoor and his four co-defendants were found guilty of racketeering conspiracy in May 2019. This charge is often used to prosecute drug dealers and mob bosses. However, this was a rare case in which the federal government used racketeering to go after corporate executives.
The Insys executives were found guilty of running a nationwide bribery scheme. The case centered on a potent opioid painkiller, Subsys, that Insys developed and aggressively marketed.